ArticleCancer medicine2025
Family History of Hypertension Predicts Thyroid Cancer Risk in Women: A Population-Based Cross-Sectional Study With Integrative Machine Learning and Genomic Analyses.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advances in immunotherapy for thyroid malignancies: from molecular targets to clinical outcomes.Frontiers in medicine · 2026Review
- Family History of Hypertension Predicts Thyroid Cancer Risk in Women: A Population-Based Cross-Sectional Study With Integrative Machine Learning and Genomic Analyses.Cancer medicine · 2025Article
- Chronic disease management: policy design based on service design methods.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThyroid cancer is one of the most common endocrine malignancies globally, with a markedly higher incidence in women. Although pregnancy-induced hypertension is recognized as a risk factor, the underlying mechanisms linking hypertension and thyroid cancer remain poorly understood. This study explores the gender-specific associations between family history of hypertension and thyroid cancer, integrating clinical characteristics with genetic insights.
methodsIn this large-scale cross-sectional study conducted in China, clinical and lifestyle data were collected from 52,963 participants, including 296 thyroid cancer cases. An interpretable ensemble machine learning model was constructed to evaluate risk factors, and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Additionally, the Cox proportional hazards model was applied to identify significant hypertension-related genes, and Kaplan-Meier analyses were used to compare overall survival, clinical stages, and immune cell infiltration between high- and low-risk groups.
resultsOur analysis revealed that individuals with a family history of hypertension exhibited a significantly altered rate of thyroid cancer (p < 0.001). In particular, among women, a positive family history increased thyroid cancer risk (OR = 1.53, 95% CI: 1.09-2.14, p = 0.04) and emerged as a key predictor in the machine learning model. Genetic analyses identified overlapping genes-most notably FOXD3, F10, and SLC12A5-whose aberrant expression was associated with poorer five-year survival and distinct immune cell profiles.
conclusionsOur study provides novel clinical and genetic evidence that family history of hypertension is significantly associated with thyroid cancer in women. Integrating hypertension-related screening with genetic profiling may enhance risk stratification and aid in the development of personalized management strategies to reduce overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.